GlaxoSmithKline settled for $64 million over a class-action lawsuit by parents whose children used antidepressant drug Paxil, the St. Louis Post-Dispatch reports.
The defective drug Paxil has reportedly caused a significant increase in suicidal thinking in children and young people taking the drug for depression. There have also been suicides reported among those in this age group taking Paxil.
Here are the specifics of the settlement:
As the Post-Dispatch reported last month, the deal was awaiting a final approval by a judge here. Last week, the judge signed off on the pact, allowing parents with proof they bought GlaxoSmithKline PLC’s Paxil and Paxil CR — a controlled-release version of the drug — for their children, to recoup out-of-pocket expenses.
In the settlement, people with documentation, such as pharmacy records or sales receipts, can file for reimbursement of their expenses. Those who lack proof they purchased Paxil for a minor, or just don’t want to track down such information, still can get a $100 refund.
Claim forms, which must be filed by Aug. 31, are available online at www.paxilpediatricsettlement.com.